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One of the few health policy issues 
that receives bipartisan support is the 
need to dramatically alter the way 
providers are paid, shifting from 
“paying for volume” to “paying for 
value.” New payment approaches and 
new organizations capable of 
accepting value-based payments are 
seen by some as transformative 
innovations that can alter the 
trajectory of health care spending 
while improving quality of care. The 
Patient Protection and Affordable 
Care Act of 2010 (ACA) has equipped 
the Centers for Medicare & Medicaid 
Services (CMS) with a range of cost-
cutting and quality-enhancing tools, 
the most significant of which might be 
the Center for Medicare and Medicaid 
Innovation (Innovation Center).  
The Innovation Center is pursuing a 
groundbreaking portfolio of payment 
and delivery reform initiatives that 
will attempt to fundamentally change 
the way we deliver and pay for care in 
the future. The ACA appropriates $10 
billion for Innovation Center activities 
initiated between and including fiscal 
years 2011 to 2019, and then 
appropriates an additional $10 billion 
for each of the following decades 
(without an end date).1 Congress 
appropriates rather than authorizes the 
Innovation Center’s funding to ensure 
that it does not have to return to 
Congress each year or even each 
decade for additional funding. 
Although $10 billion per decade 
represents a major spending 
commitment, it is still less than 0.1 
percent of Medicare and Medicaid 
spending through the end of this 
decade—far less than most 
organizations commit to research and 
development.2  
There seems to be broad agreement in 
the policy community on the 
objectives the Innovation Center was 
established to achieve. A 2011 
Commonwealth Fund/Modern 
Healthcare survey of health care 
opinion leaders found that 83 percent 
of respondents thought the Innovation 
Center was an important initiative—
support that is about 20 percentage 
points higher than for the Patient-
Centered Outcomes Research Institute 
and the Independent Payment 
Advisory Board.3  
Nevertheless, a contrary view is 
skeptical about the role of 
government, as centralized in the 
Innovation Center, in promoting and 
adopting true innovation. Advocates 
of market-based solutions to cost and 
quality problems argue that 
innovation springs from competitive 
forces—from the ground up—and 
cannot be determined and spread from 
a government agency, however 
worthy its intentions. And, perhaps 
reacting to claims by White House 
officials that the Innovation Center 
would be a source of job creation,4 
three members of the Senate Finance 
Committee recently publicly voiced 
concerns in letters to both the 
Government Accountability Office 
(GAO) and the Department of Health 
and Human Services’ (HHS) 
Secretary Sebelius. Senators Orrin 
Hatch, Mike Enzi, and Tom Coburn 
asked the GAO to review the 
Innovation Center’s activities and 
funding decisions, its fiscal impact on 
Medicare and Medicaid, and the 
degree of redundancy in CMS due to 
the Innovation Center’s existence.5 
While required to carry out initiatives 
specified in the ACA, the Innovation 
Center also has placed emphasis on 
promoting change from the ground 
up, in an attempt to be responsive to 
new ideas. In November 2011, it 
announced an Innovation Challenge to 
award between $1 million and $30 
million in grants (totaling $1 billion) 
to any applicant who proposes to 
implement compelling new ideas to 
deliver better care to people enrolled 
in Medicare, Medicaid, and the 
Children’s Health Insurance Program 
(CHIP). In various ways, the 
Innovation Center has also made a 
commitment to actively seek 
collaboration with other payers of 
health care services, including states 
and private insurance companies, to 
find common innovations in payment 
and care delivery. Since its inception, 
the Innovation Center has announced 
over a dozen major initiatives, ranging 
from a program that helps individuals 
build the skills needed to innovate 
from the ground up to a demonstration 
that invites public and private payer 
collaboration in developing a medical 
home approach to a set of initiatives 
that complement Medicare’s existing 
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accountable care organization (ACO) 
program.  
Given all of this activity, some now 
express concern that the Innovation 
Center may be doing too much too 
soon, providing overwhelming 
numbers of program options without 
an articulated vision or clear road map 
of the direction it wants the health 
delivery system to take.6 According to 
this viewpoint, the rapid succession of 
requests for proposals (RFPs) with 
tight time deadlines seems geared 
more to large, well-financed 
organizations than to the majority of 
providers who may need longer to 
generate innovative approaches. Yet, 
conversations with Innovation Center 
leadership make clear that they are 
proceeding with “a sense of urgency” 
to address the Triple Aim to (1) 
improve the individual experience of 
care, (2) improve the health of 
populations, and (3) reduce per capita 
costs of care for populations.7  
The goal of this paper is to provide a 
status report on the Center for 
Medicare and Medicaid Innovation. 
The paper first defines the goals 
Congress envisioned for the 
Innovation Center and the new tools it 
was given, emphasizing how the 
enhanced authority compares with 
CMS’ traditional demonstration 
programs. Next, the paper outlines the 
Innovation Center’s organization and 
staffing, how it sets priorities and 
decides on funding, and its approach 
to altering traditional approaches to 
testing innovative ideas, while also 
seeking a much more collaborative 
interaction with providers, other 
payers, and the public. The paper 
concludes with a description of the 
major activities to date, along with a 
table listing the projects that the 
Innovation Center has initiated so far 
(see Table 1). 
Most of the information in this paper 
was found in publicly available 
sources. We supplemented that review 
by interviewing senior leadership 
within the Innovation Center. We 
have also drawn on observations by 
some providers and delivery system 
reform experts who have interacted 
with the Innovation Center, to 
understand the perspective of those on 
the outside. To facilitate frank 
discussion, we promised that we 
would not attribute comments to 
specific individuals.  
Why Was the Innovation 
Center Created? 
Congress established the Innovation 
Center in the ACA primarily to test 
new payment and delivery models. 
The law specifically charges the 
Innovation Center with identifying, 
developing, assessing, supporting, and 
spreading new models that might 
reduce expenditures under Medicare, 
Medicaid, or CHIP while improving 
or maintaining care quality. The 
statute also suggests that the 
Innovation Center make multipayer 
initiatives one of its priorities.8  
The ACA directs the Innovation 
Center to give preference to models 
that enhance coordination, quality, 
and efficiency of care provided to 
Medicare and Medicaid beneficiaries, 
as well as those dually eligible for the 
two programs. Congress further 
suggests that the Innovation Center 
give preference to models that address 
“a defined population for which there 
are deficits in care leading to poor 
clinical outcomes or potentially 
avoidable expenditures.” The law 
suggests but does not require that it 
explore 18 priorities, called models, 
for delivery reform. 9 It is important to 
note that the ACA also enables the 
Secretary of HHS to waive certain 
provisions of existing law that 
otherwise would prevent CMS from 
testing models with alternative 
provider payment systems and/or 
coverage policies.10  
How Does the Innovation 
Center’s Authority 
Compare to CMS’ 
Traditional Demonstration 
Authority? 
The Innovation Center is in many 
ways an extension of and 
improvement on CMS’ existing 
authority to conduct demonstrations in 
Medicare, Medicaid, and CHIP. CMS’ 
authority to conduct Medicare 
demonstrations is most commonly 
based on Section 402 of the Social 
Security Amendments of 1967 (as 
amended by Section 222(b) of the 
1972 Social Security Amendments). 
CMS’ “Section 1115 Medicaid 
demonstration” authority, the most 
common source of authority for 
Medicaid demonstrations, dates back 
to 1962, when Section 1115 of the 
Social Security Act was enacted. 
Section 1115 also is the basis for 
CMS’ authority to conduct 
demonstrations under CHIP, though 
that program was created much later 
as part of the Balanced Budget Act 
(BBA) of 1997.11  
Over time, Medicare and Medicaid 
demonstrations have taken on 
different roles within each program. 
CMS uses Medicare demonstrations 
as a tool to (1) test the effectiveness of 
delivery, payment, and benefit 
innovations on a small population of 
beneficiaries or a specific geographic 
area over a short time period, and (2) 
gain operational experience applicable 
to future demonstrations or 
programmatic changes.12  
Medicaid demonstrations are used 
commonly to waive provisions of 
statute that limit the range of 
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states and provide matching federal 
funds for services and/or populations 
that otherwise would not be eligible 
for federal reimbursement. Many 
states have used Medicaid 
demonstrations to redesign significant 
portions of their programs, to the 
point, in the analysis of a Medicaid 
policy expert, that “in many states, the 
demonstrations have become the 
Medicaid programs.”13  
The Innovation Center’s authority to 
conduct demonstrations marks an 
important departure from CMS’ 
traditional demonstration authority. 
The ACA gives the Innovation Center 
a reliable stream of funding—
appropriated rather than simply 
authorized by Congress—and the 
Secretary of HHS new authority over 
the demonstration approval process, 
the scope of models to be tested, and 
the decision to scale up successful 
models to the national level.  
The Office of Management and 
Budget (OMB) actively participates in 
the development and final review of 
Innovation Center initiatives, but 
models tested, evaluated, or expanded 
under Innovation Center authority are 
exempt from OMB review and 
approval of information collections 
under the Paperwork Reduction Act 
and of CMS’ budget neutrality 
analysis.14  
However, to ensure spending 
discipline in the demonstration 
process, the Secretary is required to 
terminate or alter a demonstration 
unless the Secretary finds that the 
demonstration is (1) improving 
quality while maintaining or 
decreasing cost levels, or (2) reducing 
costs while maintaining or improving 
quality. The CMS chief actuary must 
also certify the Secretary’s findings 
regarding demonstration spending 
levels. The law, however, is silent on 
the length of time needed to make this 
determination—giving the Secretary 
flexibility on ending a 
demonstration.15  
ACA also gives the Secretary the 
authority to scale up nationally 
successful demonstrations without 
first obtaining congressional approval. 
To broaden a model, the Secretary 
must determine that such action 
“would not deny or limit [beneficiary] 
coverage or provision of benefits” to 
beneficiaries, in addition to passing 
the quality and spending 
requirements, mentioned above, for 
continuing a demonstration. The CMS 
chief actuary also must independently 
verify that model reduced trust fund 
expenditures before the Secretary can 
authorize scaling up the model.16 
Medicare Demonstration Authority  
Under CMS’ traditional Medicare 
demonstration authority, 
demonstrations can be initiated 
through an act of Congress or action 
on the part of the Secretary. Medicare 
demonstrations initiated by CMS 
under this authority generally have 
tested delivery, payment, and/or 
benefit changes. These 
demonstrations cannot proceed if they 
lower the quality of care that 
beneficiaries receive, expand program 
eligibility, or waive beneficiaries’ 
freedom to choose their providers.17 
Congress can mandate that CMS 
implement a new Medicare 
demonstration project through 
legislation or the annual 
appropriations process, or Congress 
can extend existing demonstrations 
beyond their planned date of 
completion. In the past, Congress 
mandated few Medicare 
demonstrations. Over time, Congress 
has become more active in this area. 
As of April 2010, Congress had 
mandated 17 of the 31 active or 
upcoming Medicare demonstrations in 
CMS’ active portfolio.18 Despite the 
increase in congressionally mandated 
demonstrations, funding levels in the 
2000s for research, demonstrations, 
and evaluations have varied 
considerably—ranging from $138 
million in 2001 to only $31 million in 
2008.19 
Medicaid Demonstration Authority  
Under Section 1115 demonstration 
authority, the Secretary is permitted to 
waive certain provisions of Medicaid 
statute relating to the design and 
operation of state programs. For 
example, the Secretary can waive 
provisions that cover Medicaid 
eligibility criteria, the range of offered 
services, and the delivery and 
payment system approach used in a 
state. The state also becomes eligible 
for federal matching funds to cover 
the new services or population.20  
Since Section 1115 demonstrations 
must be budget neutral, the cost of 
any proposed program expansions 
must be offset by savings to the 
program in other areas. In the past, 
states have generated savings to offset 
new costs by implementing managed 
care capitated payments (the most 
common method); redirecting 
Medicaid payments made to hospitals 
that serve a disproportionate share of 
Medicaid and/or uninsured patients; 
and limiting offered benefits to or 
increasing cost sharing for existing 
Medicaid patient populations. OMB 
also allows states to count program 
expansions already permitted under 
federal law but not adopted by the 
state as savings for the purpose of 
calculating a demonstration’s budget 
neutrality.21  
In 1993, the Clinton administration 
signaled that it would begin to use 
Section 1115 authority as a tool for 
achieving statewide health reform— 
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To pass OMB review, a demonstration’s total spending cannot exceed anticipated spending levels under existing law and must 
generate savings to offset the agency’s operational costs.1  
When the Health Care Financing Administration2 (HCFA) was created in 1977, it had almost unlimited power over the 
demonstration process. Tension between OMB and HCFA began to mount immediately over both the agency’s decisions to 
authorize certain demonstrations and the size of the Medicare budget devoted to research and demonstrations (as much as 20 percent 
of Medicare’s budget from the late 1970s to the early 1980s).3  
During the fiscal 1983 budget process, OMB assumed greater control over the demonstration process through an agreement 
brokered between then-OMB Director David Stockman and then-HHS Secretary Richard Schweiker, giving OMB clearance 
authority over demonstrations and creating the budget neutrality requirement.4  
Over the years, some have raised concerns about the narrowness of OMB’s budget neutrality review. The budget neutrality 
determination may not recognize savings generated after the demonstration period has ended—as is often the case with primary and 
secondary prevention interventions—or even savings to another government program. The budget neutrality requirement also may 
limit CMS’ ability to test ideas with unproven potential to reduce or maintain spending levels while improving quality, or ideas that 
could give CMS important operational experience that could be applied subsequently in demonstrations and program 
administration.5  
________________________________ 
1 Medicare Payment Advisory Commission. “Report to the Congress: Aligning Incentives in Medicare,” 2010. 
2 HCFA was renamed CMS in 2001. 
3 Dobson A, Moran D and Young G. “The role of federal waivers in the health policy process.” Health Affairs, 11(4): 72-94 2010; Shirk C. “Shaping Public 
Programs through Medicare, Medicaid, and SCHIP Waivers: The Fundamentals.” Washington, DC: National Health Policy Forum, 2003. 
4 Dobson et al, “The role of federal waivers in the health policy process”; Shirk, “Shaping Public Programs through Medicare, Medicaid, and SCHIP Waivers.” 
5 Cassidy M. “The Fundamentals of Medicare Demonstrations.” National Health Policy Forum, 63, 2008; Greenwald L. “Converting Successful Medicare 
Demonstrations into National Programs.” In Pay for Performance in Health Care: Methods and Approaches, Cromwell J, Trisolini M, Pope G, et al. (eds). Research 
Triangle Park, NC: RTI Press, 2011; Medicare Payment Advisory Commission, “Report to the Congress.” 
 
significantly expanding the scope of 
Medicaid demonstrations. By 2003, 
16 statewide health reform 
demonstrations were operating under 
Section 1115 authority.22  
Successes in the Traditional 
Medicare Demonstration Program  
Among the permanent programs that 
have been developed out of Medicare 
demonstrations are the hospice 
benefit, the Program of All-Inclusive 
Care for the Elderly, and competitive 
bidding for durable medical 
equipment. In addition, several 
broader initiatives have been 
developed as demonstrations, 
including the inpatient prospective 
payment system (IPPS) to replace 
cost-plus reimbursement to hospitals, 
the Medicare risk program (now 
known as Medicare Advantage), and 
other prospective payment systems.23 
The IPPS is still used today in the 
Medicare program, and this payment 
approach has been adopted by other 
U.S. payers and at least 12 European 
countries.24 
Sometimes even a negative result can 
be useful. Success can be found in 
conducting a sound demonstration 
that adequately tests a proposed 
approach and provides evidence as to 
whether the approach works or not. 
CMS’ experience with disease 
management demonstrations is a case 
in point. During the 1990s, employers 
and private health insurers began to 
use a form of disease management in 
which a nurse, usually based in a call 
center, periodically telephones 
patients with particular chronic 
conditions to provide education to 
support patient self-management and 
to monitor the patient’s condition. The 
goal was to facilitate early 
intervention to head off clinical 
deterioration that might result in a 
hospitalization. The intervention did 
not directly involve patients’ 
physicians, yet took advantage of the 
health plan’s relationship with its 
subscribers. The approach was 
considered a useful tool for delivering 
evidence-based care to those with 
chronic illnesses and widely adopted 
by private health insurers, yet never 
subjected to a rigorous evaluation to 
demonstrate its impact on patient 
well-being and health spending.25  
The CMS-sponsored demonstration, 
the Medicare Health Support (MHS) 
pilot program, was the first large 
study of this common form of disease 
management; it failed to reduce 
spending and was terminated. 
However, participants point to a 
number of problems with the 
operational implementation of the 
MHS program that suggest the need 
for so-called “rapid cycle” 
implementation, which has been 
OMB Authority to Review Budget Neutrality 
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adopted as a core approach for the 
Innovation Center, as discussed 
later.26 Whatever the operational 
lessons for conducting improved 
demonstrations, however, CMS ended 
funding of some of the pilot sites early 
because failure to engage complex 
Medicare patients in the disease 
management approach contributed to 
a reconsideration of this approach 
among private insurers as well as 
public payers, leading to a renewed 
effort to include patients’ physicians 
directly in the care management 
endeavor. 
Between 1999 and 2008, the Medicare 
program conducted seven disease 
management or care coordination 
demonstrations that included 300,000 
beneficiaries across 35 programs in 22 
states, including the MHS pilot 
program.27 As of January 2009, only 
three of the 20 programs with final 
evaluations showed evidence of 
quality improvement while being 
close to budget neutrality (minus 
fees), and early findings of the 
remaining 15 programs suggested that 
only four would be able to pay for 
their fees.28 Lessons learned from this 
experience show that three types of 
interventions can reduce 
hospitalizations among Medicare 
beneficiaries who have multiple 
chronic conditions—transitional care, 
self-management education, and 
coordinated care.29 So even “failed” 
demonstrations provide lessons that 
can be used to focus on promising 
approaches for improving care 
delivery.  
Addressing Problems in the 
Demonstration Process  
Despite these complete or partial 
successes, operational and political 
challenges have routinely constrained 
the scope and reach of Medicare 
demonstrations.30 A major challenge 
has been overcoming political 
influence and non-evidence-based 
policymaking. For example, the 
Medicare Participating Heart Bypass 
Center Demonstration, which 
operated from 1991 to 1996, tested an 
approach that used bundled payments 
for hospital and physician services for 
coronary artery bypass graft surgery. 
The subsequent evaluation showed 
that the approach cut costs by 10 
percent, reduced inpatient mortality 
rates, and improved patient 
satisfaction with nursing care, length 
of stay, and the amount of 
paperwork.31 CMS attempted to build 
on this success by implementing the 
Centers for Excellence 
Demonstration, which would have 
expanded the approach to other 
cardiac procedures and to hip and 
knee replacements, but political 
pressure from hospitals and 
physicians prevented CMS from 
following through with these efforts.32  
In many cases the problem can be 
traced to the length of the 
demonstration process. A 
demonstration that lasts one year can 
take three times that long to 
complete—one year for research and 
design, one year for operation, and 
one year for evaluation.33 Completion 
of longer demonstrations can take 
twice as long as their actual operation. 
An often cited example, the five-year 
Physician Group Practice (PGP) 
Demonstration, took more than 10 
years to complete—from enactment of 
the congressional mandate to conduct 
of the demonstration in 2000 to CMS’ 
announcement of the five-year results 
in 2011. The Medicare Coordinated 
Care Demonstration process took 
even longer; it was authorized in the 
BBA of 1997 and completed 14 years 
later.34  
The Innovation Center’s new 
authority is designed to shorten the 
demonstration process. At the front 
end, ACA exempts demonstrations 
initiated under the Innovation 
Center’s authority from OMB’s 
cumbersome and lengthy budget 
neutrality and Paperwork Reduction 
Act review. The Secretary grants the 
Innovation Center authority to 
conduct rapid cycle evaluation 
(explained below) on top of its formal 
demonstration evaluation—enabling 
the Innovation Center to produce 
usable findings for policymakers, 
providers, and other stakeholders 
more quickly. And finally, the 
Secretary’s new authority to scale up 
successful demonstration nationally or 
program-wide without new statutory 
authority will help to speed the pace at 
which policymakers act on a 
demonstration’s results. 
Another set of problems with the 
demonstration process stems from the 
perceived rigidity of CMS’ formal 
evaluation process when used to test 
all innovations. Some proposed 
innovations lend themselves more 
readily to traditional randomized trial 
methods and may fill important 
evidence gaps,35 such as the MHS 
pilot. However, under this formal 
evaluation approach, CMS is unable 
to obtain feedback from participants 
about needed alterations to the 
intervention, generate early 
assessments of impact, and then make 
midcourse corrections while the 
demonstration is operating.  
Participants in the failed MHS pilot 
observed that evaluation methods 
other than controlled trials better 
facilitate “rapid learning” and are 
more appropriate for models of care 
not well-suited to randomization.36 
Indeed, some types of complex social 
experiments, such as new models for 
providing chronic care management, 
are not conducted in laboratories but 
rather in a changing environment. 
This makes it difficult to maintain 
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control over important aspects of such 
trials, and attempts to do so can be 
counterproductive.37  
A particular challenge is whether all 
possible innovations are best tested in 
a demonstration. For example, it is not 
surprising that the PGP 
Demonstration did not cause 
providers to alter the way they deliver 
care to achieve significant reductions 
in Medicare spending. After all, the 
current fee-for-service payment 
system penalizes providers for doing 
what was asked in this demonstration: 
namely, to reduce the volume of 
services they deliver through better 
care coordination and to pay greater 
attention to evidence of what actually 
benefits patients. Given the initial 
three-year limit on CMS’ commitment 
to the payment approach used in this 
demonstration (a typical time 
commitment for demonstrations), it 
might have been foolhardy for 
participants to overhaul their business 
model, including reducing their 
revenues from hospital admissions, 
for a temporary opportunity being 
offered by only one payer, even one 
as important as Medicare.38 Yet, many 
of the operational lessons learned 
from the PGP Demonstration now 
permit CMS to proceed with the 
Shared Savings Program and the 
Pioneer ACO demonstrations, as 
discussed below.  
In short, these examples point to the 
fact that different kinds of innovation 
require different approaches to testing 
and evaluation. Some can undergo 
classic randomization in a formal trial, 
as CMS has long done. However, 
other innovations need to be tested 
with more flexible approaches, using 
rapid cycle evaluation approaches, 
and still others may need to be 
fostered without formal 
demonstrations at all because of the 
nature of the change being promoted. 
The examples also point to the need 
for a multipayer approach to test new 
models in order to magnify the power 
of new incentives, reduce 
administrative burden on providers, 
and help address unwarranted and 
contradictory variation in payment 
methods and rates across payers.39  
About the Innovation 
Center 
How Is the Innovation Center 
Staffed and Organized?  
Former CMS Administrator Donald 
Berwick, MD, named Richard 
Gilfillan, MD, acting director of the 
Innovation Center in September 2010. 
With his 20-year experience as head 
of the Institute for Healthcare 
Improvement, Berwick was actively 
involved with forming the Innovation 
Center and helping formulate its 
strategic direction. With his departure, 
Dr. Gilfillan now reports directly to 
CMS’ acting administrator, Marilyn 
Tavenner, whom President Obama 
recently nominated to become 
permanent administrator.40 A search is 
still in progress for a permanent 
director for the Innovation Center.  
The Innovation Center’s leadership 
initially arranged the organization to 
reflect its research priorities, focusing 
on three primary areas: models that 
improve care in individual episodes, 
models that cover populations across 
time and settings, and models that aim 
to improve community or population 
health. The Innovation Center has 
created corresponding research and 
model development groups: the 
Patient Care Models Group, directed 
by Director Valinda Rutledge; the 
Seamless Care Models Group, 
directed by Director Richard Baron, 
MD; and the Community 
Improvement Models Group, directed 
by Acting Director James Hester, 
PhD.41  
The Innovation Center has also 
formed a Learning and Diffusion 
Group, led by Joseph McCannon, 
which will provide technical 
assistance, introduce ideas, and spread 
successful ones; a Stakeholder 
Engagement Group, led by Mandy 
Cohen, MD, which generates 
awareness about the Innovation 
Center and communicates its activities 
to the public and stakeholders; a 
Program and Policy Group, led by 
Thomas Reilly, PhD, which focuses 
on vetting ideas the organization 
receives; and a Rapid Cycle 
Evaluation Group, led by William 
Shrank, MD.42  
The Innovation Center’s leadership 
has also created a Portfolio 
Management Committee—comprised 
of the Innovation Center’s directors, 
Dr. Gilfillan, and other senior staff—
recognizing that the lines across the 
research groups do not always 
accommodate particular initiatives. 
Innovation Center staff members 
present potential opportunities to the 
Portfolio Management Committee, 
which in turn identifies the most 
promising ideas for further 
development. This arrangement helps 
to balance workloads and increases 
collaboration among the directors and 
their groups. 
Since the Innovation Center’s creation 
in 2010, an immediate task was hiring 
staff. To expedite the hiring process, 
the Office of Personnel Management 
granted the Innovation Center direct 
hiring authority until March 2011—
enabling the organization to hire 80 
staff members in its first five months 
of existence. Six months later, the 
Innovation Center had doubled in size 
to 160 staff, due in part to the 
organization’s absorption of the 
Office of Research, Development, and 
Information’s (ORDI) evaluation and 
demonstration groups.  
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The typical CMS evaluation generally has involved independent evaluation by contracted researchers using several basic elements:  
• Careful definition of the target population and how it is to be assessed to judge success. 
• One or more comparison or control groups to serve as a benchmark for what would have happened without the 
intervention. 
• Metrics defining the outcomes of interest and how they change over time, often requiring new forms of data collection or 
unique data files. 
• Long time frames designed to distinguish immediate effects from more stable, longer term effects.1   
The evaluation designs seek to distinguish true effects of an innovation from those that can be explained by other factors, including 
secular trends, changes in patient mix, or other changes in the environment for those being evaluated.2 As discussed earlier, this 
approach does not work well to evaluate many possible innovations. To address an inflexible evaluation process, the Innovation 
Center has emphasized an approach that will enable the organization to make “rapid cycle” changes during a demonstration’s 
implementation phase.  
The Innovation Center’s Federal Register notice, which lays out the organization’s basic functions and delegated authorities, 
specifies that the Innovation Center perform “rapid cycle evaluation of innovation and demonstration activities to determine 
effectiveness and feasibility for broader dissemination, scale, and sustainability.”3 Rapid cycle evaluation offers a way for the 
Innovation Center to capture real-time data on and incorporate early insights into demonstrations as they unfold, learning from 
failure and success along the way.4   
However, although formal evaluations will still be conducted, those evaluations must deal with imperfect controls, incomplete data,5  
and even changing interventions, all leading to a probability of “messy” evaluations, in the words of a member of the Innovation 
Center leadership. In its commitment to rapid learning, the challenge for the Innovation Center will be to maintain the appropriate 
balance between scientific rigor and practical need to adapt to actual conditions being experienced by the demonstration 
participants.  
________________________________ 
1 Gold M, Helms D and Guterman S. “Identifying, Monitoring, and Assessing Promising Innovations: Using Evaluation to Support Rapid-Cycle Change.” The 
Commonwealth Fund, 1512(12), 2011. 
2 ibid. 
3 Federal Register. “Department of Health and Human Services: Centers for Medicare and Medicaid Services: Statement of Organization, Functions, and 
Delegations of Authority,” 2010. 
4 Gold et al, “Identifying, Monitoring, and Assessing Promising Innovations.” 
5 Guterman S and Drake H. “Developing Innovative Payment Approaches: Finding the Path to High Performance.” The Commonwealth Fund, 1401(87), 2010. 
 
ORDI’s demonstration group, 
renamed the Medicare 
Demonstrations Program Group under 
the Innovation Center and led by 
Linda Magno, focuses on 
demonstrations that predate the 
Innovation Center or that are 
congressionally mandated. ORDI had 
administered most of CMS’ 
demonstrations for the past decade 
under the agency’s traditional 
authority.  
CMS’ internal reorganization 
centralizes management of almost all 
Medicare and Medicaid 
demonstrations under one entity, the 
Innovation Center. With the addition 
of ORDI’s demonstrations and 
evaluations components, the 
Innovation Center has gained career 
staff who have long-term experience 
in the demonstration and evaluation 
process and thus are well positioned 
to inform the Innovation Center’s 
decisions going forward. About half 
of the Innovation Center’s staff 
consists of individuals with 
government experience. The 
Innovation Center’s leadership 
objective has been to pair directors 
who are new to government with 
experienced CMS deputy directors. 
The Innovation Center’s leadership 
has recognized the need to attract 
personnel with extensive experience 
in the private sector, other CMS units, 
other public payers, and academia; the 
Innovation Center’s commitment to 
ground-up innovation is partly based 
on already-tested approaches in use 
outside of government programs and 
in collaboration with other public and 
private payers. Likewise, the 
Innovation Center has made a point of 
recruiting seasoned CMS employees 
for leadership positions—individuals 
who, like their counterparts in the 
private sector and academia, are 
foregoing opportunities for higher pay 
and employment outside of the 
government. The Innovation Center 
has adopted a strategy of both hiring 
What Is Rapid Cycle Evaluation? 
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full-time employees and assigning 
temporary staff (who might later 
become full-time employees) through 
the Intergovernment Personnel Act 
Mobility Program. Given the 
difficulty CMS sometimes has had in 
the past in attracting staff with 
specialized private sector and 
academic expertise,43 partly because 
of inability to offer competitive 
salaries, the Innovation Center has 
been notably successful at attracting 
experienced experts willing to work at 
a General Schedule (GS) 15 salary—
in the $125,000 to $155,000 range44—
in order to be part of this new 
endeavor.  
Recently recruited staff include Nancy 
Nielson, MD, an internist and former 
president of the American Medical 
Association; Richard Baron, MD, an 
internist with experience as the chief 
medical officer of a not-for-profit 
Medicaid health maintenance 
organization and the chair of the 
American Board of Internal Medicine 
Board of Directors; James Hester, 
PhD, the former director of Vermont’s 
Health Care Reform Commission; 
William Shrank, MD, a Harvard 
professor of medicine and 
pharmacoeconomics; Joseph 
McCannon, former senior vice 
president at the Institute for 
Healthcare Improvement, who 
oversaw the 100,000 Lives Campaign 
for the Institute; Valinda Rutledge, 
former CEO of Caramont Hospital in 
North Carolina; Thomas Reilly, PhD, 
a researcher with over 20 years of 
CMS experience; and Mandy Cohen, 
MD, an internist and former executive 
director of Doctors for America. 
How Does the Innovation Center 
Prioritize Projects?  
The Innovation Center’s leadership 
sees its role as twofold: (1) 
complementing existing efforts in the 
private sector, among states, in 
Congress, and at CMS itself to 
innovate; and (2) delving into new 
ideas. Most of the Innovation Center’s 
efforts to date have focused on the 
former—implementing 
congressionally mandated 
demonstrations or ideas that Congress 
or policy experts have already 
conceived (e.g., bundled payments or 
accountable care organizations)—and 
have drawn criticism for being too 
rigid and prescriptive. More recently, 
the Innovation Center has begun to 
seek new ideas from innovators across 
the country and promote bottom-up 
innovation through its Innovation 
Challenge.  
Using ACA’s list of suggested models 
of care as a guide, the Innovation 
Center’s leadership has developed a 
list of priorities—called the Portfolio 
Criteria—that the organization is 
using to build its demonstration 
portfolio. The Innovation Center does 
not expect that prospective models 
will be able to satisfy all elements of 
the Portfolio Criteria, but rather seeks 
to develop a model portfolio that 
mirrors those priority areas.  
In addition to the Triple Aim of better 
health care, better health, and reduced 
costs, the Portfolio Criteria include 
having “the greatest potential impact 
on Medicare, Medicaid, and CHIP 
beneficiaries, and the ability to 
improve how care is delivered 
nationally,” balancing short-term and 
long-term initiatives, and examining 
health conditions that have the 
greatest potential for improving care 
while reducing costs. A full list of the 
Portfolio Criteria is available on the 
Innovation Center’s website.45  
The Innovation Center is focusing on 
testing models that fit into its priority 
areas and that it determines are worth 
exploring. In most cases, the 
Innovation Center does not work one-
on-one to fund innovators who present 
interesting proposals, but rather 
decides whether the idea can be 
converted into a model that would 
then be put into an RFP and funded on 
a competitive basis.  
The Innovation Center has not yet 
promulgated a strategic plan that lays 
out a vision for the kind of health care 
delivery system toward which it is 
working, the health care delivery 
reforms that would get us there, and a 
road map for proceeding, as called for 
by some.46 Absent a concrete strategic 
plan, the Innovation Center has 
developed a detailed list of priorities 
in which selected models must fit, a 
process for identifying and selecting 
proposals to test, and a competitive 
process by which interested parties 
can apply to participate in an 
initiative. The Innovation Center has 
not yet articulated how these priorities 
or specific initiatives fit into a larger 
plan for revolutionizing the delivery 
system. As noted earlier, some 
observers find this to be a serious 
omission.  
Once an idea has been approved by 
the Portfolio Management Committee 
and approved within the 
administration, the Innovation Center 
generates an RFP for interested 
providers and/or payers. All parties 
interested in participating in an 
Innovation Center initiative must go 
through the competitive application 
process. Some have criticized the 
Innovation Center for exchanging 
transparency and flexibility for speed 
and competitiveness in its approach—
particularly since the process 
generally does not accept applications 
on a rolling basis throughout the life 
of an initiative. Once the Innovation 
Center turns down an application for 
one of its initiatives, the opportunity 
to participate may be gone forever; 
rejected applicants have no 
opportunity to re-apply. 
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The Health Care Innovation 
Challenge offers an additional 
mechanism for a wide array of 
stakeholders to propose ideas to the 
Innovation Center. The Healthcare 
Innovation Challenge will award 
grants to applicants who can rapidly 
implement the most compelling new 
ideas to deliver better health, 
improved care, and lower costs to 
people enrolled in Medicare, 
Medicaid, and CHIP, particularly 
those with the highest health care 
needs.  
The Innovation Center considered 
establishing a Federal Advisory 
Committee Act (FACA) – compliant 
committee – an advisory body that 
could potentially include agency 
officials, issue experts, and members 
of the public and professional 
societies—to help guide Innovation 
Center priorities and to provide broad-
based support for the direction the 
Innovation Center takes,47 perhaps 
modeled after the two successful 
FACA committees implemented to 
make recommendations to the 
National Coordinator for Health 
Information Technology.48 
Ultimately, the Innovation Center’s 
leadership decided that the 
requirements of managing a FACA 
committee were potentially too 
burdensome, while the attendant 
delays to get such a committee up-
and-running ran counter to the 
urgency CMS leadership felt to get 
started. Instead, the Innovation Center 
asserts it is attempting to achieve 
similar objectives without a formal 
Advisory Committee by emphasizing 
transparency of its project solicitation 
process and through ongoing dialogue 
with the public, facilitated by the 
Stakeholder Engagement Group. For 
example, the Innovation Center 
sponsored a Care Innovations Summit 
on January 26, 2012, in collaboration 
with the Office of the National 
Coordinator for Health Information 
Technology, the West Wireless Health 
Institute, and Health Affairs.  
How Can External Innovators 
Interact with the Innovation Center?  
The Innovation Center is continually 
soliciting ideas related to ways to 
build the organization itself and new 
payment and delivery models for it to 
test. Members of the public can 
submit ideas on both topics through a 
web portal located on the Innovation 
Center’s website or through letters to 
the Innovation Center. The Innovation 
Center is set up to accept innovative 
payment and delivery reform ideas, 
feedback, and suggestions from the 
public, but not detailed proposals. 
The Innovation Center currently does 
not have the capacity to respond to 
submitted comments or release them 
(or summaries) for public 
consumption. Innovation Center staff 
use submitted comments to inform 
internal discussions about building the 
organization’s capacity and 
identifying potential models to test. 
Innovators who submit model ideas 
that the Innovation Center ultimately 
decides to test will have the 
opportunity to respond to the 
Innovation Center’s RFP on specific 
topics, but will not be afforded 
preferential treatment. 
What Initiatives Has the Innovation 
Center Started So Far?  
The Innovation Center is responsible 
for a range of demonstrations that fall 
under either CMS’ traditional 
demonstration authority or the 
Innovation Center’s new authority as 
laid out in ACA. The Innovation 
Center has inherited most of CMS’ 
existing demonstrations, which 
operate under the agency’s traditional 
authority, through its absorption of the 
demonstration group within ORDI. 
New initiatives that are 
congressionally mandated also operate 
under traditional demonstration 
authority and are administered by the 
Innovation Center. The Innovation 
Center administers new 
demonstrations unrelated to 
congressional mandates under its new 
authority.  
Since its founding, the Innovation 
Center has announced 13 new 
initiatives. This ambitious schedule 
highlights a new predicament for the 
Innovation Center’s prospective 
applicants. In most cases, to 
participate in a demonstration, they 
have to relinquish the option of 
participating in potentially more 
desirable demonstrations in the future; 
an entity’s participation in multiple 
demonstrations could potentially 
confound its evaluation. The 
Innovation Center’s policy is to 
address this problem on a case-by-
case basis, and where possible it does 
allow overlapping participation 
among its initiatives. In some 
instances, however, the Innovation 
Center has not allowed cross-
participation. For example, 
Minnesota’s statewide participation in 
the Multi-payer Advanced Primary 
Care Practice (MAPCP) 
Demonstration has precluded public 
and private payers in the state from 
applying to participate in the 
Comprehensive Primary Care 
initiative, which may offer a preferred 
approach for some. 
So far, the Innovation Center has 
announced or begun to implement 
demonstrations that address primary 
care redesign (which includes medical 
home initiatives like the 
Comprehensive Primary Care 
initiative), bundled payments, ACOs, 
dual-eligible beneficiaries, and the 
health care system’s capacity for 
spreading innovative ideas. In some 
instances, the Innovation Center is 
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implementing congressionally 
mandated demonstrations; the 
MAPCP Demonstration is one 
example. For the projects initiated 
under the Innovation Center’s 
authority, it is trying to generate top-
down and bottom-up innovation: 
taking a more prescriptive approach 
with initiatives like the Pioneer ACO 
Model initiative; creating a pathway 
for homegrown solutions to issues 
identified by the Innovation Center, as 
is the case with the Health Care 
Innovation Challenge; and allowing 
the CMS Medicare-Medicaid 
Coordination Office to take the lead 
on initiatives targeting dual-eligible 
beneficiaries. 
The appendix describes many of the 
Innovation Center’s initiatives. For a 
complete list, see Table 1. 
Conclusion 
In its first year of operation, the 
Innovation Center has a long list of 
accomplishments: attracting 
experienced personnel; developing 
processes for prioritizing and 
developing projects and for soliciting 
applicants for those projects; 
bolstering CMS thinking on several 
policy fronts, including ACOs; and 
committing to incorporating rapid 
cycle evaluation as a more flexible 
approach to determining success and 
promoting change. Concerned about 
the urgency to achieve delivery 
system change to achieve the Triple 
Aim, the Innovation Center is firing 
on all cylinders.  
Yet, some policy and health delivery 
observers express concern that the 
Innovation Center’s speed and 
approach are leaving behind potential 
innovators that have not been ready to 
respond to the quick pace of RFPs. 
They seek a more deliberative process 
that permits establishment of a 
consensus vision—and plan—for 
achieving a reformed health care 
delivery system. Exactly how such a 
consensus would be achieved remains 
unclear, given divergent views of how 
“paying for value” can best be 
achieved.  
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1/17/2012 Unspecified 4 years Payers and states in 
5-7 markets*; 75 
practices per market* 
Section 3021 of ACA 
Federally Qualified 
Health Center Advanced 
Primary Care Practice 
Demonstration 
9/16/2011 11/1/2011 3 years - ends 
on 10/31/14 
500 FQHCs (see link 
for details) 
Section 3021 of ACA 
Multi-payer Advanced 





3 years NC, ME, MI, MN, 
NY, PA, RI, VT 
Section 402 of the 
Social Security 

















Section 3021 of ACA 
 




N/A 2011 1 year (4 
sessions) 
Open to any 
organization 













4 years Physician-based and 
rural ACOs in the 
Shared Savings 
Program* 
Section 3021 of ACA 
PGP Transition 
Demonstration 
N/A 1/1/2011 2 years The 10 practices from 
the original PGP 
Demonstration 
Section 1866A(a)(1) 
of the Social Security 
Act 
Pioneer Accountable 
Care Organization Model 
Initiative 
8/19/2011 3rd or 4th 
quarter of 2011 
3 years (with 2-
year extension 
option) 
32 organizations (see 
link for details) 




Improve Care Quality for 
Nursing Facility 
Residents 
Fall 2011 Unspecified Unspecified Unspecified number 
of independent 
organizations (to 
serve up to 150 
nursing facilities)* 
Section 3021 of ACA 
State Demonstrations to 
Integrate Care for Dual-
Eligible Beneficiaries 
2/1/2011 April/May 2011 18 months (with 
extension 
option)  
CA, CO, CT, MA, 
MI, MN, NY, NC, 
OK, OR, SC, TN, 
VT, WA, WI 
Section 3021 of ACA 
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Dual-eligible Beneficiaries (cont.) 
Financial Alignment 
Model Demonstrations 
Unspecified 2012 3 years Unspecified number 
of states* 
Section 3021 of ACA 
 
Capacity to Spread Innovation 
The Partnership for 
Patients 




Transition Program (part 
of the Partnership for 
Patients) 
Applications 




1/1/2011 5 years Site selection phased-
in starting November 
2011 with 7 sites 
elected 
Section 3026 of ACA 
Innovation Advisors 
Program 
11/15/2011 12/1/2011 Ongoing (each 
cycle is 6 
months) 
73 individuals in the 
first cycle (see link 
for details); up to 200 
individuals in the 
second cycle* 
Section 3021 of ACA 
Health Care Innovation 
Challenge 
1/27/2012 3/30/2012 3 years Unspecified number 
of public and private 
organizations* 






10/14/2011 1/01/2012 target 
date 
3 years Unspecified number 
of states* 
Section 2707 of ACA 
Medicaid Incentives for 
Prevention of Chronic 
Diseases (MIPCD) 
Program 
5/2/2011 Sites awarded 
9/13/2011 
5 years WI, MN, NY, NV, 
NH, MT, HI, TX, 
CA, CT 
Section 4108 of ACA 









2012 3 years Up to 50 practices* Section 3024 of ACA 
*Participants not selected yet 
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The Innovation Center has announced or begun to implement demonstrations that address primary care redesign, bundled 
payments, ACOs, dual-eligible beneficiaries, and the health care system’s capacity for spreading innovative ideas. Below 
is a description of many of the Innovation Center’s initiatives. For a complete list, please see Table 1. 
Primary Care Redesign  
The Innovation Center is testing various models of primary care redesign. One of those models is what is called the 
advanced primary care practice (APC), also known as the patient-centered medical home (PCMH). The APC is defined as 
“a physician-based or nurse practitioner-led medical practice that provides continuous, comprehensive, coordinated, and 
patient-centered medical care.”49 
The Innovation Center has inherited a new medical home initiative that Secretary Sebelius announced in 2009: the Multi-
payer Advanced Primary Care Practice Demonstration. This project allows the Medicare program to join Medicaid and 
private payer advanced primary care initiatives (also referred to as medical homes) in eight states, but the RFP specifically 
targeted states with partnerships with private payers, not the private payers themselves.  
The Innovation Center also is implementing a medical home initiative mandated in the ACA that targets Federally 
Qualified Health Centers (FQHCs). The FQHC Advanced Primary Care Practice (APCP) Demonstration will test the 
effectiveness of the PCMH model in the FQHC setting. To be eligible to participate, FQHCs must provide primary care 
services and serve at least 200 Medicare beneficiaries (including some duals). Participating FQHCs will receive a small 
monthly management fee for each Medicare patient in their practice. The fee is intended to cover care coordination and 
other services typically delivered by PCMHs. 
In September 2011, the Innovation Center announced a medical home demonstration initiated by the Innovation Center 
called the Comprehensive Primary Care initiative. This initiative is similar to MAPCP but targets private payers as 
applicants instead of states, provides a higher per member/per month reimbursement fee for care coordination services, 
and extends for an additional year. CMS would like to collaborate with state and commercial health insurance plans in 
five to seven markets across the United States. CMS will pay primary care practices a monthly fee for coordinating care 
furnished to their Medicare patients plus the usual program fees. The additional fee will help practices lend greater 
support to patients with serious or chronic conditions, provide patients with access to care 24 hours a day, provide 
preventive care, work more closely with patients and their families, and coordinate with other physicians. Primary care 
practices will be chosen to participate in the initiative once CMS has identified the markets in which the demonstration 
will operate. Participation in the Comprehensive Primary Care initiative by state and commercial plans and providers is 
voluntary, but states (or, in the case of larger states where participation is not statewide, markets) participating in MAPCP 
are precluded from applying to the Comprehensive Primary Care initiative. 
Bundled Payments 
The Innovation Center is testing several variations on the bundled payment model. Under a bundled payment approach, 
separate payments, for example, to a hospital and physicians for services provided during an inpatient hospitalization, are 
combined into a single payment, with the goal of providing common financial incentives for the various providers to 
decrease fragmented care and improve efficiency. 
The Bundled Payments for Care Improvement initiative50 will test four approaches to bundling the care delivered around a 
hospitalization. Three of the four models would test retrospectively setting a bundled payment amount and would allow 
participating51 providers to share in the savings generated from delivering the care at a lower cost but would incorporate 
different combinations of providers. One model would test bundling payments for the acute hospital stay only, a second 
for the acute hospital stay and the associated post-acute care, and a third for post-acute care only. The latter two models 
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would also include physicians’ services, related readmissions, and other services such as clinical laboratory services. The 
fourth model would test prospectively setting a bundled payment amount for services delivered by the hospital, 
physicians, and other medical practitioners. Applicants have some flexibility to select the conditions that will be tested 
through this initiative. 
Accountable Care Organizations 
One of the Innovation Center’s highest profile priorities is testing the ACO concept. The Innovation Center defines an 
ACO as a group of providers of services and supplies “that have established a mechanism for shared governance and work 
together to coordinate care for Medicare fee-for-service beneficiaries. ACOs enter into an agreement with CMS to be 
accountable for the quality, cost, and overall care of traditional fee-for-service Medicare beneficiaries who may be aligned 
with it.”52 The Innovation Center has announced several ACO-related initiatives over the past year based on CMS’ 
experience with the PGP Demonstration. 
In January 2011, the Innovation Center extended the PGP Demonstration (renamed the PGP Transition Demonstration) 
for two additional years with some adjustments. All of the practices that participated in the initial five-year demonstration 
have agreed to participate.  
For those organizations ready to take on more risk than the Medicare Shared Savings Program allows, the Innovation 
Center will test a more aggressive approach through the Pioneer ACO Model initiative. In the first two years of the 
initiative, ACOs will operate under a shared savings and shared loss approach. After two years, ACOs that have generated 
savings will be eligible to shift to a population-based payment arrangement, akin to partial capitation. Organizations can 
participate in the Medicare Shared Savings Program or the Pioneer ACO Model initiative, but not both. 
The Innovation Center also has decided to provide start-up funding for qualifying organizations accepted into the 
Medicare Shared Savings Program. The Advanced Payment ACO Model will give eligible ACOs a portion of their share 
of the savings in advance of actually generating those savings, to make the infrastructure and staffing investments needed 
to succeed as an ACO.  
Dual-eligible Beneficiaries 
A growing body of research shows that dual-eligible beneficiaries have substantially higher medical spending than other 
populations on average yet are less likely to receive coordinated care. Duals represent 16 percent of Medicare 
beneficiaries yet are responsible for 25 percent of Medicare spending. Even more striking, duals comprise 18 percent of 
Medicaid beneficiaries and 46 percent of Medicaid spending.53  
Since care for duals is reimbursed through two completely separate funding streams, neither program takes responsibility 
for coordinating the care delivered to these beneficiaries. Each program uses coverage rules to avoid costs. Medicare 
generally provides restorative and recuperative care, while Medicaid often pays for care that maintains or prevents further 
decline in health. At times, classifying services as restorative or maintaining the status quo can be ambiguous. For 
example, Medicaid, which covers the long-term care of nursing home residents, has a financial incentive to hospitalize 
those beneficiaries; Medicare covers their hospitalization and the first 100 days of nursing home care following a hospital 
stay.54  
To address this unique set of challenges, ACA established the Medicare-Medicaid Coordination Office, which focuses on 
coordinating dual-eligible beneficiaries’ care, improving access to high-quality care, and making the system more cost-
effective. This office is taking the lead on the design, implementation, and evaluation of new state-based payment and 
delivery system reform demonstrations, but the initiatives are being implemented through the Innovation Center’s 
authority and funding.55 Although the initial emphasis has been on state-based demonstrations, whether states or the 
federal government should hold primary responsibility for the care—and consequently cost containment—for duals 
remains controversial.56 
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The Innovation Center launched its first initiative targeting duals in April 2011. For the State Demonstrations to Integrate 
Care for Dual Eligible Individuals, CMS is working with 15 states to develop person-centered approaches to care 
coordination for duals. Each participating state will receive up to $1 million to develop its approach and produce a 
specific proposal.  
In July 2011, CMS announced that the Innovation Center would be conducting two additional demonstrations targeting 
duals. One, the Innovation Center is administering a demonstration that would reduce preventable inpatient 
hospitalizations among long-term nursing facility residents, although the approach may also benefit other nursing facility 
residents. Organizations separate from nursing facilities would implement evidence-based interventions in nursing 
facilities with high hospital admission rates and a large share of duals.  
Two, the Innovation Center released guidance to states on a new demonstration that would test two financial approaches 
to aligning Medicare and Medicaid reimbursement for duals’ care: a capitated approach and a managed fee-for-service 
model (meaning fee-for-service that maintains freedom to choose providers but adopts some managed care techniques, 
such as requiring beneficiaries to obtain authorization from the insurer or payer prior to filling a prescription from the 
treating physician). Under the capitated approach, a state, CMS, and a managed care plan would sign a three-way contract 
whereby Medicare and Medicaid would provide to the plan a blended prospective payment to cover the full range of 
needed care. States and CMS will jointly choose plans through a competitive selection process. Under the managed fee-
for-service approach, a state and CMS would agree to make the state eligible for a share of the Medicare savings 
generated from managed fee-for-service initiatives that are designed to improve quality and lower Medicare and Medicaid 
costs. States would provide an up-front investment to support care coordination in return for a share of Medicare savings 
once a specific savings threshold is reached. The states participating in the State Demonstrations to Integrate Care for 
Dual Eligible Individuals also are encouraged to use these models in their plans.  
Capacity for Spreading Innovation 
In April 2011, Secretary Sebelius announced the creation of a national public-private partnership called the Partnership for 
Patients to encourage homegrown improvements in patient safety and care quality across the health care system. The goal 
of the partnership is to reduce hospital-acquired conditions by 40 percent and 30-day hospital readmissions by 20 percent 
over the next three years. To help its private sector partners facilitate improvements in patient safety and quality, the 
Innovation Center has promised to award up to $500 million for initiatives that support the partnership’s goals.  
CMS is supporting hospitals and other providers participating in the Partnership for Patients by making available an 
additional $500 million for a Community-based Care Transition Program established in the ACA. This program is 
designed to help hospitals and community-based organizations improve the care that Medicare beneficiaries at high-risk 
of readmission receive as they transition from the hospital to other sites of care.  
More recently, the Innovation Center has established an initiative to improve the health care system’s capacity for 
developing innovations beyond the patient safety and care transitions targeted in the Partnership for Patients initiative. 
Specifically, the Innovation Center has created a program designed to broadly help individuals refine, apply, and sustain 
managerial and technical skills necessary to drive delivery system reform for Medicare, Medicaid, and CHIP 
beneficiaries, called the Innovation Advisors Program. The objective is to facilitate participants becoming part of a 
network of experts, who can support the Innovation Center as it tests new models, provide a unique set of skills and 
knowledge regarding their communities or areas of expertise, collaborate with other local organizations to facilitate 
change in the delivery system, develop innovative ideas for testing, and develop skills in system improvement in their 
region.  
The Innovation Center is seeking up to 200 individuals with expertise in health care economics, population health, 
systems analysis, and operations research to apply to the new program. Seventy-three advisors have been selected for the 
first of two cycles. Participants are expected to spend 10 hours per week working on Center activities during the first six 
months of their fellowship. Part of that time will be spent on seminars and instruction, and the rest will be spent 
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developing the improvement project proposed in their application to the program. Participants will remain employees of 
their home organization but will receive a stipend from the Innovation Center.  
As previously noted, the Innovation Center has also issued a challenge to innovators across the country to develop and 
implement new initiatives that deliver better health, improved care, and lower costs to Medicare, Medicaid, and CHIP 
beneficiaries, called the Health Care Innovation Challenge. The Innovation Center is specifically targeting initiatives that 
will expand the health care workforce and improve worker efficiency. Applicants who are selected will receive grants 
ranging from $1 million to $30 million, depending on their proposals. Prospective applicants could include providers, 
payers, local governments, public-private partnerships, and multipayer collaboratives. The Innovation Center has set aside 
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